Agios Pharmaceuticals SG&A Expense (Quarterly) Analysis

Agios Pharmaceuticals Inc (AGIO)

31.48 -0.19 (-0.60%) USD | NASDAQ | Apr 26, 16:00

31.48 0.00 (0.00%) After-Hours: 17:45

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	35.30M
September 30, 2023	25.82M
June 30, 2023	30.41M
March 31, 2023	28.37M
December 31, 2022	32.77M
September 30, 2022	29.12M
June 30, 2022	28.26M
March 31, 2022	31.52M
December 31, 2021	31.53M
September 30, 2021	27.15M
June 30, 2021	29.22M
March 31, 2021	33.55M
December 31, 2020	25.91M
September 30, 2020	28.35M
June 30, 2020	29.18M
March 31, 2020	31.67M
December 31, 2019	4.807M
September 30, 2019	33.02M
June 30, 2019	32.39M
March 31, 2019	31.79M
December 31, 2018	31.86M
September 30, 2018	31.10M
June 30, 2018	26.63M
March 31, 2018	24.55M

Date	Value
December 31, 2017	22.71M
September 30, 2017	17.46M
June 30, 2017	16.13M
March 31, 2017	14.82M
December 31, 2016	15.38M
September 30, 2016	11.85M
June 30, 2016	12.64M
March 31, 2016	10.84M
December 31, 2015	10.18M
September 30, 2015	9.927M
June 30, 2015	8.929M
March 31, 2015	6.954M
December 31, 2014	6.501M
September 30, 2014	5.166M
June 30, 2014	4.165M
March 31, 2014	3.288M
December 31, 2013	3.707M
September 30, 2013	2.534M
June 30, 2013	1.836M
March 31, 2013	1.852M
December 31, 2012	1.554M
September 30, 2012	1.58M
June 30, 2012	1.948M
March 31, 2012	1.981M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.807M

Minimum

Dec 2019

35.30M

Maximum

Dec 2023

28.86M

Average

29.22M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks